NEWCaplight raises a $16M Series A, led by BlackRock and Fin Capital →
Skip to main content
Caplight Logo









MatriSys Bioscience

MatriSys Bioscience

Private
La Jolla, CaliforniaHealthcare & Life Scienceshttps://matrisysbio.com/

Last Round

Series A

Jul 15, 2022

Total Funding Raised

$14.5M

Company Overview

MatriSys Bioscience is a biotechnology company that develops microbiome-based therapeutics for the treatment of chronic skin diseases.

Sector

Healthcare & Life Sciences

Verticals

Biotechnology, Drug Discovery, Clinical Trials, Precision Medicine

Business Model

B2B

Customer Profile

Services & Consulting

AI Layer

Non-AI

Keywords

live biotherapeutic productsLBPskin microbiomemicrobiome therapydermatologyatopic dermatitisacne treatmentbiopharmaceuticalskin homeostasismicrobiome drugsbacterial therapeuticsNetherton syndromeprecision medicinegut-skin axis

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

MatriSys Bioscience Comps

Public and private peers based on sector, stage, and business model.

MatriSys Bioscience comps — public and private peers by sector, stage, and business model
CompanyStatusEst. ValuationRev Multiple
OpenAIPrivate$86.0B~40x
CoherePrivate$5.0B--
Competitor 1Public$XX.XBXXx
Competitor 2Public$XX.XBXXx

View Full Comps Set

Access detailed peer comparisons, multiples, and valuation benchmarks.

MatriSys Bioscience Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
Series AJul 15, 2022
DebtMar 11, 2021
VC RoundMar 11, 2021
Convertible DebtJan 5, 2017

MatriSys Bioscience Investors

Notable investors and investment history

MatriSys Bioscience investors
InvestorRounds
National Institute of Allergy and Infectious DiseasesVC Round
Mesa Verde Venture PartnersVC Round, Series A
ALMA Life SciencesSeries A
TCA Venture GroupSeries A, Convertible Debt

Market signals

Structured signals derived from secondary market and firmographic data.

  • Feb 2, 2026

    Monthly visitors increased 63% MoM.

MatriSys Bioscience Filings

SEC and related filings with document metadata.

Data table
TypedDateAmount OfferedAmount SoldFillingPagesDownload
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation

MatriSys Bioscience Filings

SEC and related filings with document metadata.

Frequently Asked Questions

Common questions about MatriSys Bioscience's valuation, stock price, and market status.

Firmographic Details

HeadquartersLa Jolla, California
Employee Range6
Year Founded2015
Last FundingJul 15, 2022

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.